Copaxone (glatiramer acetate) is prescribed to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary progressive MS (SPMS). It helps reduce the frequency of relapses and slows the progression of the disease.